BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Drug Development

  GlaxoSmithKline Release: Avandia(R) (rosiglitazone maleate) Reduced Risk Of Progression From Pre-Diabetes To Type 2 Diabetes By 62 Percent In Largest Completed Diabetes Prevention Trial

  September 15, 2006

   · 

  9 min read
• Drug Development

  Molecular Biomarkers Predicting Efficacy Of Introgen Therapeutics, Inc.'s ADVEXIN Cancer Therapy Are Highlighted At Major Cancer Conference

  September 15, 2006

   · 

  1 min read
• Pharm Country

  Callisto Pharmaceuticals Release: To Combat Often Fatal Orphan Diseases, A Small Pharmaceutical Company Leads New Drug Investigation

  September 15, 2006

   · 

  1 min read
• Genetown

  Pressure BioSciences, Inc. To Present At The Wall Street Analyst Forum’s 17th Annual Analyst Conference

  September 15, 2006

   · 

  1 min read
• Genetown

  AMICAS, Inc. To Present At The 2006 UBS Warburg Global Life Sciences Conference

  September 15, 2006

   · 

  1 min read
• Pharm Country

  Auxilium Pharmaceuticals Announces Sale Of Common Stock

  September 15, 2006

   · 

  1 min read
• Devgen NV On Track In Implementation Of Business Plan

  September 15, 2006

   · 

  1 min read
• Business

  Array BioPharma, Inc. Receives Phase 2 Milestone Payment From AstraZeneca PLC

  September 15, 2006

   · 

  1 min read
• BioMidwest

  Aastrom Biosciences, Inc. To Present At Merriman Curhan Ford & Co. 3rd Annual Investor Summit

  September 15, 2006

   · 

  1 min read
• Drug Development

  MethylGene Initiates Phase II Clinical Trial With Proprietary HDAC Inhibitor, MGCD0103, In B-Cell Lymphoma

  September 15, 2006

   · 

  1 min read